Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2012 Jul 12.

Published in final edited form as: J Am Coll Cardiol. 2011 Jul 12;58(3):232–237. doi: 10.1016/j.jacc.2011.01.051

Table 1.

Clinical characteristics

	Lean (n=17)	Obese (CLS-) (n=31)	Obese inflamed (CLS+) (n=78)
Age (yrs)	33 ± 12	40 ± 10	43 ± 12^*
Female (%)	77	97	82
BMI (kg/m²)	22 ± 1	45 ± 7^*	45 ± 9^*
Waist circumference (cm)	76 ± 1	127 ± 6^*	130 ± 7^*
Weight (kg)	63 ± 7	118 ± 20^*	127 ± 29^*
Insulin (mU/ml)	2, 1	10.5, 7^*	14, 12^*^†
HOMA	0.5, 0.2	2.3, 1.7^*	4.1, 3.4^*^†
Triglycerides (mg/dl)	62, 34	83, 43^*	107, 89^*
Glucose (mg/dl)	86,10	92, 21^*	100, 26^*
HDL-C (mg/dl)	67 ± 18	49 ± 9^*	49 ± 14^*
LDL-C (mg/dl)	97 ± 24	115 ± 26^*	121 ± 31^*
Total cholesterol (mg/dl)	178 ± 29	183 ± 29	194 ± 36
HbA1c (%)	5.3 ± 0.3	6.1 ± 1.0^*	6.3 ± 1.1^*
hs-CRP (mg/dl)	0.9 ± 0.9	5.1 ± 3.9^*	8.5 ± 9.5^*
Diabetes (%)	0	26^*	36^*
Hypertension (%)	0	36^*	46^*
Hypoglycemic use (%)	0	13	32^*
Lipid lowering use (%)	0	13	26^*
Active smoker (%)	0	16	8

Data are presented as means ± SD or median, interquartile range.

^*

p<0.05 vs. lean;

^†

p<0.05 vs. CLS- obese